Latest Schedule 13D activist filings

Michael and Klil Zisapel have increased their beneficial ownership in RadCom Ltd. to 14% following the inheritance of shares from their late father, co-founder Zohar Zisapel.

Galloway Capital Partners has increased its stake in Noodles & Company to 8.78%, expressing confidence in the company's recovery and believing shares are undervalued.

Elliott Investment Management L.P. has reduced its direct beneficial ownership in Southwest Airlines Co. to 9.3% while maintaining confidence in the airline's strategic initiatives.

Gerald T. Proehl, President and CEO of Dermata Therapeutics, Inc., updated his beneficial ownership to 17.3% of the company's common stock.

Saba Capital Management, L.P. and affiliates reported a reduction in their beneficial ownership of abrdn Life Sciences Investors to 4.95% through open market sales.

Activist investor Tice Brown, holding 9.8% of Empery Digital Inc., rejected a management buyback offer and renewed calls for CEO Ryan Lane's resignation, a new Board, and immediate Bitcoin liquidation.

BW Group Limited has reduced its beneficial ownership in DHT Holdings to 8.37% through a series of open market share sales.

Bios Capital Management and related entities report a combined 8.58% beneficial ownership in Lantern Pharma Inc. common stock.

A significant shareholder and director of Braemar Hotels & Resorts Inc., Bob Ghassemieh, has resigned from the board following allegations of policy violations and a dispute over the company's advisory agreement.

South Dakota Investment Council has reduced its beneficial ownership in Bristow Group Inc. to 7.3% through recent open market sales.

Jefferson River Capital and related entities have reduced their beneficial ownership in Renalytix plc to below the 5% threshold.

The Chiliz Group Ltd. has increased its beneficial ownership in Processa Pharmaceuticals, Inc. to 13.0% through a recent share purchase.

Star Financial Corp has converted $4.43 million of debt into 2 million common shares of ZenaTech, Inc., increasing its beneficial ownership to 9.49%.

Parex Resources, holding an 11.8% stake in GeoPark Ltd., has nominated six independent directors to GeoPark's board and made an all-cash offer for Frontera Energy's Colombian assets.

Select Medical Holdings Corp's Executive Chairman, Robert A. Ortenzio, has submitted a refined non-binding proposal to acquire all outstanding shares not already owned by the reporting persons for $16.00 per share in cash.

Gilead Sciences, Inc. announces a definitive agreement to acquire Arcellx, Inc. for approximately $8.1 billion, including a contingent value right, following a tender offer.

Gilead Sciences, Inc. announced a definitive agreement to acquire Arcellx, Inc. for approximately $7.8 billion in cash and contingent value rights.

Brian Harris, a key executive at Ladder Capital Corp, increased his beneficial ownership to 6.8% through open market purchases and a significant equity grant.

Organigram Global Inc. is set to fully acquire Sanity Group GmbH, with British American Tobacco's subsidiary increasing its strategic investment through a share-based consideration and a significant private placement.

A group of investors, including Bradley L. Radoff and Michael Torok, has formed to collectively own 6.5% of Seer, Inc. Class A Common Stock, intending to engage with management on strategic review and board composition.

GG Mars Capital, Inc. has increased its beneficial ownership in ZenaTech, Inc. to approximately 8.298% through the conversion of a convertible line of credit.

Northstrive Fund II LP and Braeden Lichti, holding a 5.05% stake, have filed a Schedule 13D urging enVVeno Medical Corp to halt clinical operations and explore strategic alternatives including liquidation or merger.

Northstrive Fund II LP and Braeden Lichti, holding a 5.05% stake, demand enVVeno Medical Corp halt clinical operations and initiate a strategic review for capital return or merger.

Oramed Pharmaceuticals Inc. has increased its beneficial ownership in Nano Dimension Ltd. to 5.2%, expressing strong dissatisfaction with the issuer's management and strategic direction.

Oramed Pharmaceuticals Inc. has increased its beneficial ownership in Nano Dimension Ltd. to 5.2%, expressing strong dissatisfaction with the issuer's management and strategic direction.

Core Scientific, Inc. and Two Seas Capital LP have entered a cooperation agreement, leading to significant board changes and a standstill on Two Seas Capital's share accumulation.

United Acquisition SPAC LLC and CEO Paul Packer report beneficial ownership of 27.3% of United Acquisition Corp. I's ordinary shares following the company's IPO.

Charles Kohnen has filed a Schedule 13D, revealing an 8.12% beneficial ownership in SCI Engineered Materials, Inc. and signaling potential engagement with management on strategic matters.

Lennar Corporation and its affiliates have filed an exit amendment to their Schedule 13D, indicating they no longer beneficially own more than five percent of Hippo Holdings Inc. common stock.

Lennar Corporation and its affiliates have filed an exit amendment to their Schedule 13D, indicating they are no longer beneficial owners of more than five percent of Hippo Holdings Inc. common stock.